These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 12793576)

  • 21. A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT).
    Turpie AG; Bauer KA; Davidson BL; Fisher WD; Gent M; Huo MH; Sinha U; Gretler DD;
    Thromb Haemost; 2009 Jan; 101(1):68-76. PubMed ID: 19132191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A combination of arteriovenous impulse system and low-molecular-weight heparins calcium for prophylaxis of deep venous thrombosis following total knee arthroplasty].
    Cao J; Wang J; Zhang H; Wang L
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2010 May; 24(5):538-40. PubMed ID: 20540254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BAY 59-7939: an oral, direct factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study.
    Turpie AG; Fisher WD; Bauer KA; Kwong LM; Irwin MW; Kälebo P; Misselwitz F; Gent M;
    J Thromb Haemost; 2005 Nov; 3(11):2479-86. PubMed ID: 16241946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of enoxaparin to prevent deep vein thrombosis after hip arthroplasty.
    Colwell CW; Spiro TE
    Clin Orthop Relat Res; 1995 Oct; (319):215-22. PubMed ID: 7554633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement.
    Turpie AG; Gallus AS; Hoek JA;
    N Engl J Med; 2001 Mar; 344(9):619-25. PubMed ID: 11228275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A meta-analysis of thromboembolic prophylaxis in total knee arthroplasty.
    Brookenthal KR; Freedman KB; Lotke PA; Fitzgerald RH; Lonner JH
    J Arthroplasty; 2001 Apr; 16(3):293-300. PubMed ID: 11307125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Development of an apparatus for preventing deep vein thrombosis].
    Chen XM; Wen CA; Gu DQ
    Zhongguo Yi Liao Qi Xie Za Zhi; 2005 Jul; 29(5):331-3. PubMed ID: 16419935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preventing recurrence after deep vein thrombosis.
    Prescrire Int; 2012 Nov; 21(132):275. PubMed ID: 23210266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of deep-vein thrombosis after total knee replacement.
    Goldberg A
    J Bone Joint Surg Br; 2000 Mar; 82(2):304-5. PubMed ID: 10755445
    [No Abstract]   [Full Text] [Related]  

  • 30. [Low molecular-weight heparin (clexane) in the prevention of thrombotic events in patients with malignancies].
    Somonova OV; Madzhuga AV; Elizarova AL; Sel'chuk VIu; Zubrikhina GN; Bokhian AIu
    Klin Lab Diagn; 2006 Aug; (8):31-3. PubMed ID: 17087245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postoperative physical therapy for podiatric surgery.
    Saxena A; O'Brien T
    J Am Podiatr Med Assoc; 1992 Aug; 82(8):417-23. PubMed ID: 1507080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Authors Respond.
    Bily W; Franz C; Trimmel L; Kasche W; Kern H; Loefler S; Zampieri S; Sarabon N; Cvecka J; Zenz P
    Arch Phys Med Rehabil; 2016 Nov; 97(11):2018-2019. PubMed ID: 27780527
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevention of deep vein thrombosis in knee arthroplasty. Preliminary results from a randomized controlled study of low molecular weight heparin vs foot pump compression.
    Norgren L; Toksvig-Larsen S; Magyar G; Lindstrand A; Albrechtsson U
    Int Angiol; 1998 Jun; 17(2):93-6. PubMed ID: 9754896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomised comparison of a foot pump and low-molecular-weight heparin in the prevention of deep-vein thrombosis after total knee replacement.
    Warwick D; Harrison J; Whitehouse S; Mitchelmore A; Thornton M
    J Bone Joint Surg Br; 2002 Apr; 84(3):344-50. PubMed ID: 12002490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deep vein thrombosis prevention in joint arthroplasties: continuous enhanced circulation therapy vs low molecular weight heparin.
    Gelfer Y; Tavor H; Oron A; Peer A; Halperin N; Robinson D
    J Arthroplasty; 2006 Feb; 21(2):206-14. PubMed ID: 16520208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overview of enoxaparin in the treatment of deep vein thrombosis.
    Deitcher SR
    Am J Manag Care; 2000 Nov; 6(20 Suppl):S1026-33. PubMed ID: 11484302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomised comparison of a foot pump and low-molecular-weight heparin in the prevention of deep-vein thrombosis after total knee replacement.
    Hidalgo-Ovejero AM; Garcia-Mata S; Martinez-Grande M; Otermin-Maya I
    J Bone Joint Surg Br; 2003 May; 85(4):619-20; author reply 620. PubMed ID: 12793576
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.